Anastassia Amaro MD, a University of Pennsylvania endocrinologist and the Company’s advisor state “the interim analysis of the MVL procedure demonstrates safety and early efficacy which I find very encouraging for patients suffering from Type 2 diabetes”.
Medality Medical is pursuing a surgical solution to improve the lives of patients with Type 2 Diabetes(“T2D). The patented HydraSolve T2DTM System safely removes the mesenteric visceral fat (fat around the intestines) in order to improve glycemic control of type 2 diabetes. If T2D is not controlled, long-term complications such as heart attacks, strokes, blindness, kidney failures and amputations are serious unavoidable consequences of this disease.
A worldwide epidemic
 International Diabetes Federation. IDF Diabetes Atlas, 8th edition, 2017, Brussels, Belgium: http://www.diabetesatlas.org
 Evaluation of Treatment Persistence in Individuals with Type 2 Diabetes in a Real-World Setting; WILLIAM T. CEFALU et. al. Diabetes 2018 Jul; 67(Supplement 1): -. https://doi.org/10.2337/db18-135-OR
In early 2018, study results were published in the peer-reviewed journal, Surgery for Obesity and Related Diseases, in an article entitled: Mesenteric visceral lipectomy using tissue liquefaction technology reverses insulin resistance and causes weight loss in baboons. Based upon the non-human primate study results, it is anticipated there will not be any dietary restrictions or nutritional supplementation that is typical for other gastric surgery alternatives.
In this Company’s published pre‐clinical non‐human primate trial funded by the National Institutes of Health (“NIH”) and led by Mark Andrew, MD, the Company’s Founder and Chief Scientific Officer, reversal of insulin resistance, a precursor of T2D, was achieved and was the basis for having received the necessary approvals to commence the Pilot Trial.
Patient recruitment of the Pilot trial conducted at the University of Texas Health Science Center at San Antonio (“UTHSCSA”) is underway. For more information please visit the HydraSolve T2D page.